has been cited by the following article(s):
|
[1]
|
Validität der wissenschaftlichen Publikationen, die der S3-Leitlinie zum exokrinen Pankreaskarzinom zu Grunde liegen
|
|
2019 |
|
|
|
|
[2]
|
Where Have All the Experienced Clinicians Gone? How the Literature on Care of Older Persons Fails to Adequately Inform Clinical Decision Making
|
|
2019 |
|
|
|
|
[3]
|
Vergleich internationaler Leitlinien zur Therapie des Ösophaguskarzinoms
|
|
2018 |
|
|
|
|
[4]
|
Validität der wissenschaftlichen Publikationen, mit welchen die Behandlung des Kolonkarzinoms in Leitlinien begründet wird
|
|
2017 |
|
|
|
|
[5]
|
Klinische Ökonomik–Was sie ist, was sie will und weshalb wir sie brauchen
|
|
Gesundheits?konomie & Qualit?tsmanagement,
2017 |
|
|
|
|
[6]
|
Entwicklung eines Verfahrens zur Evaluierung von Screeningstudien anhand einer vielbeachteten Studie zum Lungenkarzinom-Screening aus dem Jahre 2011
|
|
2016 |
|
|
|
|
[7]
|
Validität von systematischen Reviews der Cochrane Collaboration
|
|
2016 |
|
|
|
|
[8]
|
CLINICAL ECONOMICS–IT IS ABOUT VALUES NOT ABOUT MONEY
|
|
2016 |
|
|
|
|
[9]
|
Prüfung der Validität von wissenschaftlichen Studien zu Glaukomscreening
|
|
2015 |
|
|
|
|
[10]
|
Benefits and Risks of Breast Cancer Screening
|
|
Oncology Research and Treatment,
2014 |
|
|
|
|
[11]
|
Can Perioperative Chemotherapy for Advanced Gastric Cancer Be Recommended on the Basis of Current Research? A Critical Analysis
|
|
Journal of gastric cancer,
2014 |
|
|
|
|
[12]
|
Benefits and risks of breast cancer screening.
|
|
Oncology research and treatment? ,
2014 |
|
|
|
|
[13]
|
The risks of information in health care: do we need a new decision aid?
|
|
Clinics,
2013 |
|
|
|
|
[14]
|
Correspondence (letter to the editor): Balancing Conflicts of Interest
|
|
Deutsches ?rzteblatt International ,
2013 |
|
|
|
|
[15]
|
To Strengthen Health Education on Medical Students in the Information Age
|
|
2013 International Conference on Computer, Education and Information Management (CEIM 2013),
2013 |
|
|
|
|
[16]
|
?konomisierung oder Kommerzialisierung der Gesundheitsversorgung
|
|
Public Health Forum, Elsevier,
2013 |
|
|
|
|
[17]
|
Correspondence (letter to the editor): Risk Awareness and Transparency
|
|
Deutsches ?rzteblatt International ,
2013 |
|
|
|
|
[18]
|
Correspondence (reply): In Reply
|
|
Deutsches ?rzteblatt International ,
2013 |
|
|
|
|
[19]
|
Validität der wissenschaftlichen Publikationen, die der S3–Leitlinie zum exokrinen Pankreaskarzinom zu Grunde liegen
|
|
|
|
|
|
|
[1]
|
Where Have All the Experienced Clinicians Gone? How the Literature on Care of Older Persons Fails to Adequately Inform Clinical Decision Making
Journal of the American Medical Directors Association,
2019
DOI:10.1016/j.jamda.2019.05.019
|
|
|
|
|
[2]
|
Benefits and Risks of Breast Cancer Screening
Oncology Research and Treatment,
2014
DOI:10.1159/000363595
|
|
|
|
|
[3]
|
Can Perioperative Chemotherapy for Advanced Gastric Cancer Be Recommended on the Basis of Current Research? A Critical Analysis
Journal of Gastric Cancer,
2014
DOI:10.5230/jgc.2014.14.1.39
|
|
|
|
|
[4]
|
The risks of information in health care: do we need a new decision aid?
Clinics,
2013
DOI:10.6061/clinics/2013(09)01
|
|
|
|
|
[5]
|
In Reply
Deutsches Ärzteblatt international,
2013
DOI:10.3238/arztebl.2013.0287
|
|
|
|
|
[6]
|
Balancing Conflicts of Interest
Deutsches Ärzteblatt international,
2013
DOI:10.3238/arztebl.2013.0286a
|
|
|
|